BRIEF-Novavax announces positive topline data from phase 2 trial and provides path forward for RSV F vaccine programs
July 24, 2017 at 16:24 PM EDT
* Novavax announces positive topline data from phase 2 older adult trial and provides path forward for RSV F vaccine programs Source text for Eikon: Further company coverage: